nav-left cat-right
cat-right

Clinical Trials in Asia Summit 2009

4th Annual Pharmacovigilance Conference

Determining the prospective strategies for Implementing Clinical trials in India & South Asia – Today’s Hottest Market

18th – 20th May 2009, The Park, New Delhi, India

 

Key Speakers
• Chandrashekhar Potkar, Director, Medical and Regulatory Affairs, Pfizer, India
• Viraj Rajadhyaksha, Senior Manager, Operations, Planning & Mgmt Clinical Research,
Pfizer, India
• Rajesh Karan, Regional Head of Translational Medicine & Scientific Operations,
Novartis, India
• Anirban Roy Chowdhury, Clinical Research Manager, AstraZeneca, India
• Subbaraju Sagi, Senior Sales Consultant,Oracle Health Sciences
• Mark Engel, Chairman, Excel PharmaStudies, China
• Celestine Juliet, Project Manager, Cipla
• Krathish Bopanna, Senior Vice President,
Acunova
• Nermeen Varawalla, Vice President, Scientific & Medical Affairs,
PRA International, London
• Paula Mumby, Director,
i3 Pharma Resourcing
• Dan Zhang, CEO
, Fountain Medical Development, China
• Dalvin Ni, VP,
Fountain Medical Development, China
• Milind Antani, Head-Pharma
LifeSciences group, Nishith Desai
• Arun Bhatt, President, Clininvent Research
• Arani Chatterjee, Vice President,

 

India has all the competitive advantages for conducting clinical trials. As the country is increasingly becoming a favored destination for clinical trials, a gap analysis needs to be done to scale up all resources for clinical trials. This scale up is essential for India to cope with the large global clinical trial projects. It is no coincidence over the last decade or more of economic liberalization, and years of unprecedented growth, that India and parts of South Asia are becoming a preferred clinical research destination for multinational pharmaceutical and biotechnology corporations.

Clinical Trials Summit 2009 will discuss the on-going pressing concerns faced in clinical trials operations, addressing the risks, timeline and budget constraint, whilst effectively tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This year, the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management will be discussed in order to improve and optimize the overall drug development effectiveness and ROI. Find out how to implement and benefit from electronic data management & monitoring cost effectively. This event will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance. Delegates will have the opportunity to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and China, selection and role of CROs, logistics of operations, clinical trials management, government policies (including IPR issues) and pharmacovigilance.

Reasons to register today:
• How can you take advantage of the global market for clinical trials?
• Improving and optimizing site management and overall productivity of clinical operations
• Optimising clinical trials operation effectiveness and ROI through strategic site, patient, data and risk management in the regulated markets
• Identify the data management, CMC supply chain, operational requirements and CRO infrastructure in India and South Asia
• Gaining insights on future forwards of clinical trials and valuing its potential
• Discover how to improve your supplier-client relationships
• Complete trials on schedule and budget by learning to overcome hurdles in investigator/patient recruitment
• What are the issues with off-shoring trials to countries such as India & South Asia? What are the ways to overcome them?
• Explore innovative strategies for outsourcing, what you should be looking for in a CRO?
• Working with limited budget to ensure on time study completion
• Escalating patient recruitment and improving patient retention to save cost and reduce lead-time
• Maximizing trials results through overseas multinational/multi-centric trials
• Avoiding potential pitfalls of trials agreement
• Motivating and managing clinical project teams to improve timeline and progress 

 

Who should attend?
From pharmaceutical, biotech and CRO’s: Directors and Heads of:
• Clinical Research & Development
• Clinical Research Services
• Clinical Operations
• Clinical Data Management
• Clinical IT
• Clinical Trials
• Medical Affairs
• Regulatory Affairs
• Compliance
• Quality Control/Assurance/GCP
• Clinical Study Design
• Safety Surveillance
• Subject Recruitment
• E-Clinical Systems

 

Location
The Park, New Delhi
15 Parliament Street, New Delhi, 110001
Tel: +91 011 2374 3000 Ext 1902, Fax: +91 11 233629320

HTML clipboardwww.visiongain.com